{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiaxdhx2cdc35rmz3tcf53tfij6uevu652xsgwjxaihwgu3kjd42j4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mggv7jhgimi2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiegjj2nc5htmsga5zhgui6o3ckibqpzwa74gzfre67ifxp7fq6e6i"
    },
    "mimeType": "image/jpeg",
    "size": 103431
  },
  "path": "/news/2026-03-aaaai-omalizumab-effective-multifood-oral.html",
  "publishedAt": "2026-03-06T22:20:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Individuals with one to three allergenic foods are able to introduce and continue eating allergenic foods at 12 months after multifood oral immunotherapy (mOIT) or omalizumab, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology, held from Feb. 27 to March 2 in Philadelphia.",
  "title": "AAAAI: Omalizumab as effective as multifood oral immunotherapy for individuals with food allergy"
}